Discover how Type III Transforming Growth Factor-beta receptor (TβRIII) alteration plays a crucial role in pancreatic cancer progression and treatment resistance.
Exploring how next-generation sequencing and cell-free DNA testing are transforming pancreatic cancer detection and prediction.